Bioequivalence Study of ICI176,334-1 in Japanese Healthy Male Subjects - Evaluation of Bioequivalence of ICI176,334-1 and Casodex 80 mg Tablet.
Phase of Trial: Phase I
Latest Information Update: 29 Feb 2012
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 29 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 29 Feb 2012 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
- 29 Feb 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.